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Time seriesTemporal trends of polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and dioxin-like
polychlorinated biphenyls (DL-PCBs) in mothers' milk are still quite rare. Data are particularly scarce when it
comes to concentrations from the last decade, 2000 and onwards. The aims of the present study were to assess
temporal trends of PCDD, PCDF and DL-PCB inmothers' milk from Stockholm, 1972–2011 and to compare the re-
sults with previous analysis of some of the older samples.
The samples were analyzed by high resolution GC/MS and results were statistically evaluated for the periods,
1972–2011 and 2002–2011. The rate of which∑PCDDs,∑DL-PCBs and the∑TEQ are decreasing (on pg/g
fat WHO-TEQ2005) is higher in the last decade compared to the 40 year period, 1972–2011. A similar trend is
indicated, but not conﬁrmed, for∑TEQ of PCDFs, probably due to too many PCDF congeners below LOQ in the
period 2002–2011. Concentrations of∑PCDDs,∑PCDFs,∑DLPCBs and∑TEQ, all expressed as pg/g fat on
TEQ-WHO2005-basis, show a statistically signiﬁcant decline over time, 5.8–6.8% per year, 1972–2011. The last ten
years the annual declines for∑PCDDs,∑DL-PCBs and∑TEQ are 9.2–11% and for∑PCDF, 5.4%. Congener speciﬁc
trend analysis, 2002–2001, of PCDDs and DL-PCBs showed the same pattern, while the PCDF congeners showed no
such general trend. The results from the re-analysis showed good agreement with slightly lower∑TEQ1998 pg/g
fat concentrations in six out of seven samples and mean difference of 13% in∑TEQ1998. The study shows that
time series can be elongated from previous studies, as long as the sample population remains the same.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
WHO initiated biomonitoring of persistent organic pollutants (POPs)
in mothers' milk in 1976 and so far ﬁve rounds of the global survey
have been carried out during 1987–2010 (UNEP, 2012; WHO, 2009).
The aim of the global survey is to assess the concentrations of POPs, so
far with emphasis on polychlorinated dibenzo-p-dioxins (PCDDs), diben-
zofurans (PCDFs) and dioxin-like (DL) biphenyls (DL-PCBs), hereafter re-
ferred to as “dioxins” in this article. The mothers' milk program is now
part of the Stockholm Convention (Stockholm Convention). Apart from
on the Stockholm Convention website, dioxin concentrations in mothers'
milk around the world have been summarized in several publications
(LaKind, 2007; Srogi, 2008; Tanabe and Minh, 2010). In particular,
LaKind (2007) has made a comprehensive compilation and analyzed
global data on∑TEQ1998 concentrations, including temporal trends. To. Open access under CC BY-NC-ND license.summarize the ﬁndings by LaKind, the concentrations are decreasing
globally (1975–2005). However, the study did not report a decline in
the last years, 2003–2005. National/regional time trend studies show
similar decreasing trends of “dioxins”, including studies from Australia
(Harden et al., 2004), Russia (Mamontova et al., 2005), Norway (Becher
et al., 2002), Sweden (Lignell et al., 2009), and Japan (Hori et al., 1999).
In a review from 1996, temporal trends up to that point are summarized
and in short, studies from Germany, The Netherlands, Norway and
Sweden all show the same general declining trend of ∑TEQ values
(Alcock and Jones, 1996). Croes and coworkers summarized the results
from a WHO mothers' milk survey from the European countries which
show decreasing trends of∑TEQ concentrations (Croes et al., 2013). In
contrast, a study from Japan reports status quo of the “dioxin” concentra-
tions, 1998–2004 (Kunisue et al., 2006). Studies with samples from the
last decade aremore limited but showdecreasing “dioxin” concentrations
in Belgium (Croes et al., 2012), Ireland (Pratt et al., 2012) and Spain
(Schuhmacher et al., 2009). In Sweden, Norén and coworkers started
monitoring of mothers' milk already in 1970. A large number of articles/
reports concerning levels and time trends of POPs in mothers' milk
from this monitoring program are summarized (with some new original
data included) in a review article from the year 2000 (Norén and
Table 1
Data on sampling year, number of donating mothers in each pool, which samples that
were previously analyzed for PCDD/Fs and DL-PCBs and double samples analyzed.
Year Mothers Mean age
(years)
Primiparae
(%)
Previously
analyzeda
Two
samples
1972 75 27–28 NAb YES
1974 90 27–28 NAb YES
1976 78 27–28 NAb YES
1978 87 27–28 NAb
1980 116 27–28 NAb YES
1988/89 140 30 58
1990 60 30 65 YES
1991 60 28 56 YES
1992 40 29 65 YES
1995 20 30 65
1997 40 31 65 YES
1999 20 31 70
2000 10; 10 30 75 YES
2001 20 30 80
2002 10; 10 30 80 YES
2003 15 31 67
2004 10; 10 30 80 YES
2007 10; 10 27 100 YES
2008 9; 9 28 100 YES
2009 10; 10 31 100 YES
2010 10; 9 30c 100 YES
2011 11; 11 30 100 YES
a Norén and Meironyte (2000).
b Not available.
c Only available for 5 out of 19 mothers.
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This is supported by Lignell et al. (2009), who report decreasing levels
of POPs, including “dioxins”, in mothers' milk from Sweden during
1996–2006.
Only a few time series with multiple year sampling of mothers' milk
exists, especially with samples from the last decade. In this study we re-
analyze a set of samples from the original (composite) time trend study
(Norén and Meironyte, 2000), to test comparability, as well as new
samples from 1999 to 2011. This will help us answer if the decreasing
concentrations of “dioxins” are leveling off, i.e. what is the trend for the
ﬁrst decade of the 21st millennia, and if it is possible to compare the
established concentrations from previous studies directly. Hence, the
aims of the present study were to assess temporal trends of PCDD,
PCDF and DL-PCB in mothers' milk from Stockholm, 1972–2011, and to
compare the resultswith previous analyses of some of the older samples.2. Materials and method
Three major concerns were considered when choosing mothers'
milk samples; i) to ensure comparability between the new and the pre-
vious analyses of Swedishmothers' milk; ii) to add samples taken in the
past to ﬁll gaps in the previous time trend and iii) to expand the afore-
mentioned time trend study ending in 1997 (Norén and Meironyte,
2000) to obtain data ranging from 1972 to 2011. In total, 30 samples
were analyzed and eight of these were non-identical samples from a
given year. The samples consisted of pooled mothers' milk from multi-
ple donors, all healthy native Swedish, but were not exclusively from
primiparae. Further information concerning sample composition is
presented in Table 1.
The samples, 50 g each, were provided by the Swedish Environ-
mental Specimen Bank, Department of Environmental Research and
Monitoring, Swedish Museum of Natural History. The samples were
prepared in house before they were shipped, on dry ice, to Euroﬁns
GfA Lab Service GmbH, Hamburg, Germany, for analysis according to
the method described by Reis et al. (2007). In brief the method could
be described as follows: 13C-labeled surrogate standards were added
to the samples followed by liquid–liquid extraction and subsequentgravimetric lipid determination prior to multiple column clean-up, in-
cluding carbon column puriﬁcation. The puriﬁed extracts were ana-
lyzed by GC/HRMS.
2.1. Statistical methods
To test for signiﬁcant log-linear trends for PCDDs, PCDFs and DL-
PCBs, log-linear regression analysis was performed for the entire in-
vestigated time period and for the most recent 10 years using the yearly
arithmeticmean values. In caseswhere the regression line had a poor ﬁt,
a 3-point running mean smother was checked for statistical signiﬁcance
in comparison with the regression through an ANOVA (Nicholson et al.,
1998). Potential outliers in the temporal trends were detected using a
method described by Hoaglin andWelsch (1978). The suspected outliers
are merely indicated in the ﬁgures and were included in the statistical
calculations. Values below level of quantiﬁcation (LOQ) were replaced
by LOQ/2 prior to the statistical analyses. Power analysis was also carried
out. The power was ﬁxed to 80% and the minimum possible trend to be
detected during a monitoring period of 10 years at a signiﬁcant level of
5% was estimated. A signiﬁcance level of 5% was used for all tests.
3. Results
Individual PCDDandPCDF congener concentration data are presented
in Table 2, for each of the pooled mothers' milk samples analyzed, and
with concentrations given on aweight basis per gram fat. Table 2 also in-
cludes∑PCDD/PCDF concentrations, but expressed on basis of WHO-
TEQ1998 and WHO-TEQ2005, in pg/g fat (Van den Berg et al., 1998; Van
den Berg et al., 2006). The corresponding data are reported in Table 3
for DL-PCBs,∑DL-PCBs and∑TEQ (WHO1998 and WHO2005).
Based on the results presented in Tables 2 and 3, it is possible to cal-
culate and present temporal trends of the analytes as determined in
Stockholm mothers' milk from 1972 to 2011. Time series analyses
were performed for all analytes and selected temporal trend data are
presented as graphs in Figs. 1–4.
Temporal trends, 1972–2011, for ∑PCDDs, ∑PCDFs, ∑DL-PCBs
and∑TEQ (i.e. the sum of∑PCDDs,∑PCDFs and∑DL-PCBs), based
on pg/g fat WHO-TEQ2005 concentrations, are presented in Fig. 1a–d).
The relative annual decrease over the 40 year period for PCDDs,
PCDFs, DL-PCBs and∑TEQs are 6.1%, 6.1%, 6.9% and 6.5% respectively,
with p b 0.001 in each case. The relative annual decreases over the last
ten years for PCDDs, PCDFs, DL-PCBs and∑TEQs are 10% (p b 0.001),
7.3% (p b 0.001), 12% (p b 0.012) and 10% (p b 0.002), respectively. The
number of years required to detect an annual change of 10% varied
between 6 and 10 years for the groups in Fig. 1a–d). The power to detect
a 10% annual change was 100% for all of the full time series. The smallest
possible trend to detect varied between 3.7 and 9.4% change per year
during a decade.
Temporal trends, 1972–2011, for 2,3,7,8-TCDD, 1,2,3,7,8-PCDD and
1,2,3,6,7,8-HCDD, based on concentrations in pg/g fat, are presented in
Fig. 2a–c). The relative annual decrease over the 40 year period for
2,3,7,8-TCDD, 1,2,3,7,8-PCDD and 1,2,3,6,7,8-HCDD are 6.1%, 5.9% and:
6.0% with p b 0.001 in each case. The annual relative decrease over
the last ten years for 2,3,7,8-TCDD, 1,2,3,7,8-PCDD and 1,2,3,6,7,8-
HCDD are 11%, 10% and: 10%, respectively, with p b 0.001 in each
case. The number of years required to detect an annual change of 10%
varied between 9–11 years for the three PCDD congeners and the
power to detect a 10% annual change was 100% for the full time series.
The smallest possible trend to detect varied between 6.9–19% change
per year during a decade.
Temporal trends, 1972–2011, of 2,3,7,8-TCDF, 2,3,4,7,8-PCDF,
1,2,3,7,8-PCDF and 2,3,4,6,7,8-HCDF, based on concentrations in pg/g
fat, are presented in Fig. 3a–d). The relative annual decrease over the
40 year period for 2,3,7,8-TCDF, 2,3,4,7,8-PCDF, 1,2,3,7,8-PCDF and
2,3,4,6,7,8-HCDF are 6.5%, 6.1%, 5.7% and 6.7%, respectively, with
p b 0.001 in each case. The annual relative decrease over the last ten
Table 2
Concentrations (pg/g fat) of seven PCDDand ten PCDF congeners are presented. Also,WHO-TEQ1998 andWHO-TEQ2005 are presented for the sum of PCDDs and PCDFs (Van den Berg et al.,
1998, 2006).
1972 1974 1976 1978 1980 1988/89 1990 1991 1992 1995 1997 1999 2000:1 2000:2 2001
Fat content (%) 2.5 3.2 2.9 3.0 2.9 2.4 2.6 2.6 2.9 3.1 2.9 3.1 3.0 2.7 3.0
PCDD
2,3,7,8-TetraCDD b2.8 3.5 5.2 3.0 3.4 2.4 1.8 7.5 1.7 1.5 1.2 1.1 0.89 1.1 0.90
1,2,3,7,8-PentaCDD 9.4 7.2 7.3 7.8 7.1 5.2 4.8 4.1 3.8 3.6 3.3 2.7 2.0 2.2 2.3
1,2,3,4,7,8-HexaCDD 3.5 3.1 2.4 3.0 3.4 2.3 1.9 1.7 1.6 1.3 1.4 1.1 0.82 0.86 0.79
1,2,3,6,7,8-HexaCDD 28 23 24 27 25 20 20 15 16 14 12 9.8 7.3 8.1 8.3
1,2,3,7,8,9-HexaCDD 3.1 1.9 1.7 2.0 5.6 2.3 2.3 3.0 2.1 2.5 2.0 1.3 1.2 1.5 1.0
1,2,3,4,6,7,8-HeptaCDD 95 80 78 79 69 48 42 31 27 25 24 17 13 16 13
OctaCDD 430 340 320 380 330 230 240 170 140 110 110 96 74 80 77
PCDF
2,3,7,8-TetraCDF 3.0 2.1 2.1 2.4 2.3 1.5 1.3 1.0 0.78 0.64 0.68 0.57 0.47 0.53 0.45
1,2,3,7,8-PentaCDF 1.3 0.84 0.76 1.0 0.66 0.46 0.43 0.39 0.30 0.26 0.28 0.24 0.23 b0.26 0.23
2,3,4,7,8-PentaCDF 31 23 25 26 22 14 13 10 10 10 8.7 7.2 5.5 6.1 6.3
1,2,3,4,7,8-HexaCDF 14 9.1 8.5 8.5 6.7 3.8 3.5 2.7 2.6 2.2 2.0 1.9 1.6 1.6 1.5
1,2,3,6,7,8-HexaCDF 7.7 5.5 5.4 5.6 4.7 3.1 2.8 2.4 2.3 1.9 1.9 1.7 1.4 1.5 1.4
1,2,3,7,8,9-HexaCDF b0.28 b0.21 b0.27 b0.24 b0.22 b0.28 b0.28 b0.26 b0.24 b0.22 b0.24 b0.22 b0.25 b0.29 b0.22
2,3,4,6,7,8-HexaCDF 3.2 2.5 2.2 2.1 1.8 1.3 1.2 1.0 0.93 0.79 0.76 0.70 0.59 0.69 0.59
1,2,3,4,6,7,8-HeptaCDF 35 25.0 18 16 12 4.9 5.5 3.7 4.1 2.4 3.0 2.2 2.4 2.3 2.1
1,2,3,4,7,8,9-HeptaCDF 0.69 0.40 0.43 0.43 0.43 b0.27 b0.27 b0.26 b0.23 b0.21 b0.24 b0.21 b0.24 b0.28 b0.22
OctaCDF 1.9 1.2 1.6 0.81 1.0 2.2 b0.83 b0.79 b0.71 b0.66 b0.73 b0.65 b0.75 b0.88 b0.67
∑PCDD/F
∑PCDD/F (WHO-TEQ1998)a 32 28 31 30 27 19 17 20 14 13 11 9.3 7.2 8.0 7.9
∑PCDD/F (WHO-TEQ2005)a 26 24 26 25 23 16 14 18 12 11 9.5 7.9 6.1 6.8 6.7
2002:1 2002:2 2003 2004 2007:1 2007:2 2008:1 2008:2 2009:1 2009:2 2010:1 2010:2 2011:1 2011:2
Fat content (%) 3.4 3.6 2.8 3.7 3.9 3.9 4.1 3.5 4.0 3.0 4.0 3.8 3.2 3.7
PCDD
2,3,7,8-TetraCDD 0.87 0.85 0.86 0.68 0.39 0.59 0.38 0.34 0.33 0.34 0.32 0.44 0.38 0.33
1,2,3,7,8-PentaCDD 2.3 1.9 2.1 1.7 1.2 1.5 1.1 0.78 1.1 0.87 0.92 1.1 1.0 0.85
1,2,3,4,7,8-HexaCDD 0.84 0.67 0.88 0.62 0.53 0.67 0.38 b0.34 0.39 0.40 0.30 0.51 0.42 0.36
1,2,3,6,7,8-HexaCDD 7.3 6.2 7.2 5.1 4.5 5.1 3.3 2.4 4.2 2.5 2.3 3.5 3.4 2.8
1,2,3,7,8,9-HexaCDD 1.1 1.0 0.94 0.80 0.96 1.3 0.67 0.74 0.71 0.68 0.55 0.70 0.73 0.69
1,2,3,4,6,7,8-HeptaCDD 14 9.2 12 7.2 6.1 8.6 5.8 4.0 4.8 3.8 4.2 4.2 5.8 6.2
OctaCDD 60 54 64 48 42 56 39 31 30 25 27 32 38 34
PCDF
2,3,7,8-TetraCDF 0.41 0.60 0.62 0.38 b0.40 0.58 0.49 b0.47 b0.37 b0.50 b0.38 b0.40 b0.45 b0.40
1,2,3,7,8-PentaCDF b0.19 0.26 0.27 b0.18 b0.28 b0.28 b0.28 b0.32 b0.26 b0.35 b0.26 b0.28 b0.31 b0.28
2,3,4,7,8-PentaCDF 6.1 5.4 5.7 4.6 3.2 4.7 3.4 2.5 2.8 3.0 3.0 3.9 3.1 2.9
1,2,3,4,7,8-HexaCDF 1.5 1.3 1.5 1.2 1.2 1.3 1.1 1.0 0.83 1.0 0.78 1.2 1.0 0.92
1,2,3,6,7,8-HexaCDF 1.4 1.3 1.4 1.1 1.0 1.1 1.0 0.85 0.81 0.89 0.76 1.1 1.0 0.84
1,2,3,7,8,9-HexaCDF b0.21 b0.20 b0.26 b0.20 b0.31 b0.31 b0.31 b0.36 b0.29 b0.39 b0.29 b0.31 b0.35 b0.31
2,3,4,6,7,8-HexaCDF 0.70 0.54 0.54 0.52 0.45 0.63 0.61 0.53 0.48 0.49 0.37 0.51 0.52 0.51
1,2,3,4,6,7,8-HeptaCDF 9.5 1.6 1.6 1.6 2.7 3.4 1.8 1.9 1.0 1.1 1.1 1.1 2.2 1.2
1,2,3,4,7,8,9-HeptaCDF b0.21 b0.19 b0.25 b0.19 b0.30 b0.30 b0.30 b0.35 b0.28 b0.38 b0.28 b0.30 b0.34 b0.30
OctaCDF b0.63 b0.59 b0.78 b0.59 b0.93 b0.93 b0.92 b1.1 b0.86 b1.2 b0.87 b0.92 b1.0 b0.92
∑PCDD/F
∑PCDD/F (WHO-TEQ1998)a 7.8 6.7 7.3 5.8 4.2 5.6 4.1 3.0 3.6 3.4 3.3 4.3 3.7 3.3
∑PCDD/F (WHO-TEQ2005)a 6.6 5.7 6.1 4.9 3.6 4.7 3.4 2.5 3.0 2.8 2.7 3.6 3.1 2.7
a Sums are calculated using LOQ/2 for analytes below LOQ.
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(p b 0.002) 7.9% (p b 0.001) and 5.3% (p b 0.001) respectively. No tem-
poral concentration trend could be discerned for 1,2,3,7,8-PCDF, during
the last ten years. The number of years required to detect an annual
change of 10% varied between 7–9 years for the PCDF congeners
and the power to detect a 10% annual change was 100% for all of the
full time series. The smallest possible trend to detect varied between
3.4–7.9% change per year during a decade.
Temporal trends, 1972–2011, of the DL-PCB congeners, CB-118, CB-
126 and CB-156 based on concentrations in pg/g fat are presented in
Fig. 4a–c). The relative annual decrease over the 40 year period for
CB-118, CB-126 and CB-156 are 7.6%, 7.0% and 5.8%, respectively, with
p b 0.001 in each case. The annual relative decrease over the last ten
years for CB-118, CB-126 and CB-156 are 9.7% (p b 0.001), 12%
(p b 0.015) and 8.1% (p b 0.003), respectively. The number of yearsrequired to detect an annual change of 10% was 7–10 years, and the
power to detect a 10% annual change was 100% for the full time series.
The smallest possible trend to detect varied between 5.2%-9.0% change
per year during a decade.
4. Discussion
The present study conﬁrms decreasing temporal trends of the∑TEQ
of∑PCDDs,∑PCDFs and∑DL-PCBs assessed herein (Table 2, Fig. 1).
Likewise, it conﬁrms signiﬁcant concentration declines of the individual
PCDD, PCDF and DL-PCB congeners analyzed. This was to be expected
as the time series covers 40 years. The data are in accordance with previ-
ously obtained data for∑PCDDs,∑PCDFs and∑DL-PCBs in mothers'
milk from Stockholm, 1972–1997 (Norén andMeironyte, 2000). Howev-
er, it is striking to see a steeper rate of decline over themost recent years,
Table 3
Concentrations (pg/g fat) of 12 DL-PCB congeners and the TEQ levels of each milk sample, using both the WHO TEQ1998 and TEQ2005 are shown (Van den Berg et al., 1998, 2006).
1972 1974 1976 1978 1980 1988/89 1990 1991 1992 1995 1997 1999 2000:1 2000:2 2001
Fat content (%) 2.5 3.2 2.9 3.0. 2.9 2.4 2.6 2.6 2.9 3.1 2.9 3.1 3.0 2.7 3.0
PCB
PCB 77 150a 33 21 28 28 21 36 120a 15 b9.8 b11 b9.7 b11 b13 b10
PCB 81 17 6.2 6.3 6.6 6.9 4.0 3.0 13 2.1 b1.3 1.5 1.7 b1.5 b1.8 1.5
PCB 105 14000 12000 13000 12000 9400 5200 5000 3900 3700 3400 2700 2200 1600 1900 1600
PCB 114 1900 1600 1700 2100 1600 1100 1000 860 790 780 670 490 350 490 480
PCB 118 64000 53000 56000 55000 43000 26000 25000 19000 18000 17000 14000 11000 8100 9400 8100
PCB 123 680 540 560 570 450 260 260 200 170 160 130 100 83 92 92
PCB 126 240 220 230 180 160 82 89 60 69 79 71 35 42 48 39
PCB 156 20000 15000 17000 19000 16000 12000 11000 9300 9300 8100 7700 6400 4900 6000 5400
PCB 157 3300 2800 3000 3400 2900 2200 2000 1700 1700 1500 1300 1200 880 1100 1000
PCB 167 7500 6000 6700 6800 5700 3900 3700 3000 2800 2600 2100 1900 1400 1500 1400
PCB 169 92 69 63 74 63 51 44 41 41 40 35 33 27 30 26
PCB 189 1600 1300 1400 1600 1300 940 1000 810 830 700 670 640 410 510 560
∑DL-PCB (WHO-TEQ1998)b 46 39 42 38 32 20 20 15 16 16 14 9.3 8.6 10 8.7
∑DL-PCB (WHO-TEQ2005)b 30 26 28 24 21 11 12 8.4 9.3 10 9.0 5.2 5.5 6.3 5.2
∑TEQ
∑TEQ (WHO-TEQ1998)b 78 67 73 68 60 38 37 35 29 28 25 19 16 18 17
∑TEQ (WHO-TEQ2005)b 56 50 54 48 44 27 26 26 21 21 19 13 12 13 12
2002:1 2002:2 2003 2004 2007:1 2007:2 2008:1 2008:2 2009:1 2009:2 2010:1 2010:2 2011:1 2011:2
Fat content (%) 3.4 3.6 2.8 3.7 3.9 3.9 4.1 3.5 4.0 3.0 4.0 3.8 3.2 3.7
PCB
PCB 77 b9.5 b8.9 b12 b8.9 b14 b14 b14 b16 b13 b17 b13 b14 b16 b14
PCB 81 1.5 b1.2 1.8 1.3 b1.8 b1.9 b1.8 b2.2 b1.7 b2.3 b1.7 b1.8 b2.1 b1.8
PCB 105 1500 1700 1700 1400 930 1600 840 660 770 880 830 1100 680 810
PCB 114 430 360 450 300 190 300 200 150 150 200 220 280 180 150
PCB 118 8100 8100 8800 6400 4600 7000 4400 3400 3800 3700 3900 5100 3400 3900
PCB 123 78 89 94 66 45 79 47 38 51 45 43 62 35 43
PCB 126 34 54 38 32 28 43 13 10 20 12 19 20 17 17
PCB 156 4500 4100 4600 3200 2600 3700 2600 1900 2300 1800 2500 2900 2500 1800
PCB 157 880 680 880 640 460 650 460 330 360 330 450 540 430 320
PCB 167 1300 1200 1400 970 710 910 610 460 570 460 540 630 520 480
PCB 169 24 23 21 17 16 18 14 b10.8 13 b11.6 13 13 16 b9.2
PCB 189 390 360 410 300 220 340 190 150 220 130 190 230 200 140
∑DL-PCB (WHO-TEQ1998)b 7.6 9.2 8.1 6.3 5.2 7.6 3.6 2.6 4.0 2.8 4.1 4.6 3.8 3.3
∑DL-PCB (WHO-TEQ2005)b 4.7 6.6 5.0 4.1 3.6 5.2 2.0 1.2 2.6 1.4 2.5 2.7 2.4 1.9
∑TEQ
TOTAL-TEQ (WHO-TEQ1998)b 15 16 15 12 9.4 13 7.7 5.6 7.6 6.1 7.4 8.9 7.5 6.6
TOTAL-TEQ (WHO-TEQ2005)b 11 12 11 8.9 7.2 9.9 5.4 3.7 5.7 4.2 5.2 6.2 5.5 4.6
a Values contain a degree uncertainty due to poor recovery of the corresponding 13C-labeled surrogate standard.
b Sums are calculated using LOQ/2 for analytes below LOQ.
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In contrast, the steepness of the ∑PCDF TEQ decreasing time trend
has not changedmuchover time. Several of the PCDFs are belowLOQdur-
ing the latter 10 years, allowing no trend analysis, while 2,3,7,8-TCDF
and 2,3,4,7,8-PCDF (WHO-TEF2005 = 0.1 and 0.3) both show stronger
and signiﬁcant declines over the recent 10 years. However, 1,2,3,4,7,8-
HCDF and 1,2,3,6,7,8-HCDF (WHO-TEF2005 = 0.1 and 0.1) show a sim-
ilar signiﬁcant decrease as over the 40 year period. 2,3,4,6,7-HCDF and
2,3,4,6,7,8-HCDF show no statistical signiﬁcant trend (p N 0.05) for
the last decade. Still, a majority of the PCDD, PCDF and DL-PCB conge-
ners decrease faster during the last decade than during the whole
40 year period and the congeners that do not decrease are difﬁcult to as-
sess since they all have several concentration points below LOQ. Altogeth-
er we therefore conclude that the “dioxins” decline faster today than
previous decades. This is to be regarded as a positive outcome of the
management of dioxin sources and the ofﬁcial advice given to pregnant
andnursingwomen in Sweden (NFA, 2013). The results reported herein
are particularly good news for nursingmothers and their children, both
in Sweden and beyond. The latter, because the steeper decline of dioxins
inmothers'milk over the last decade conﬁrms that it is possible tomake a
change through strict management of dioxin sources.It is previously reported that certain, in particular PCDF, congeners
do not show decreasing time trends (Lignell et al., 2009; Pratt et al.,
2012; Solomon andWeiss, 2002). In these reports no statistically signif-
icant decreases of temporal trends were observed for 2,3,7,8-TCDF,
1,2,3,7,8-PCDF and 2,3,4,6,7,8-HCDF, between 1996 and 2006. The in-
crease in concentration of 2,3,4,7,8-PCDF between sampling times
reported in Irish mothers' milk (Pratt et al., 2012) could not be ob-
served in the present study. In fact, a tenfold decrease for the whole
series and a halving of the concentrations between 2002 and 2010,
see Table 2, duplicate samples for 2002: 5.4; 6.1 and 2010: 3.0; 3.9 pg/g
fat, for the same sampling years as the Irish study. The authors of
the Irish study explain the increase of 2,3,4,7,8-PCDF as a result of the
selected sampling groups, changing from a rural to a more urban
population.
When looking into the actual concentrations of “dioxins” in mothers'
milk reported in recent years (milk that includes samples from 2008
and later) the∑TEQ2005 place the Swedish concentrations (this study)
in the lower end of dioxin exposures (Table 4). This is supported by
the∑TEQ1998 concentrations, all of which are higher than the Swedish
concentrations. The∑PCDD/Fs (both TEQ1998 and TEQ 2005) concen-
trations reported in the current study are comparatively low, but still
Table 4
Concentrations of “dioxins” reported in selected, recent studies with concentrations expressed in pg/g fat (Van den Berg et al., 1998, 2006).
Country Year ∑PCDD/F
(mean)
TEQ1998
∑PCDD/F
(mean)
TEQ2005
∑PCDD/F
(median)
TEQ2005
∑DL-PCB
(mean)
TEQ1998
∑DL-PCB
(mean)
TEQ2005
∑TEQ
(mean)
TEQ1998
∑TEQ
(mean)
TEQ2005
Reference
Africa '05–'11 3.6 UNEP (2011)
Antigua & Barbuda '07–'09 4.3 UNEP (2009)
Asia & the Paciﬁc '05–'11 4.5 UNEP (2011)
Belgium '09–'10 8.4a 6.9a 5.8a 3.7a 14a 11a Croes et al.
(2013)
Central & Eastern
Europe
'05–'11 5.9 UNEP (2011)
Chile '07–'09 9.7 UNEP (2009)
Ghana '07–'09 3.2 UNEP (2009)
GRULACb '05–'11 5.6 UNEP (2011)
Ireland 2010 6.32 3.34 9.66 Pratt et al. (2012)
Italy '08–'09 4.6–6.1 3.8–4.9 6.2–6.9 4.8–5.7 11–13 8.6–11 Ulaszewska et al.
(2011)
Italy '08–'09 4.3–15c Bianco et al.
(2013)
Korea '07–'09 4.0 UNEP (2009)
Nigeria '07–'09 3.1 UNEP (2009)
Senegal '07–'09 7.2 UNEP (2009)
Sweden 2011 3.3; 3.7 2.7; 3.1 3.3; 3.8 1.9; 2.4 6.6; 7.5 4.6; 5.5 Current study
Uruguay '07–'09 6.9 UNEP (2009)
Western Europe &
other States
'05–'11 6 UNEP (2011)
Vietnam 2008 2.7; 6.6 Nhu et al. (2011)
Vietnam 2008 5.2 Manh et al.
(2013)
a Geometric mean concentrations.
b Group of Latin America & Caribbean Countries.
c TEQ not speciﬁed.
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centrations of ∑DL-PCBs, but the concentrations obtained in this
study are low to medium. The study from Croes et al. (2013) alsopg/g fat PCDD
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Fig. 1. Temporal trends of TEQ(WHO-2005) for PCDDs, PCDFs, DL-PCBs and∑TEQ (∑TEQ PCDD
2011. The linear red lines (p b 0.05) are based on log-linear regression analyses. The red, as
smoothers ﬁtted to the annual mean values. A red cross represents a suspected outlier.includes concentrations obtained from CALUX-assays. These are not
included in Table 4 since more comparable, GC–MS analysis derived,
results from the same samples are available.pg/g fat dl−PCB
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Fig. 2. Temporal trends of 2,3,7,8-TCDD, 1,2,3,7,8-PCDD and 1,2,3,6,7,8-HCDD (pg/g fat) in mothers' milk from Stockholm, 1972–2011. The linear red lines (p b 0.05) are based on log-
linear regression analyses. The red non-linear lines (p b 0.05) are smoothers ﬁtted to the annual mean values. A red cross represents a suspected outlier.
229J. Fång et al. / Environment International 60 (2013) 224–231In order to certify the analytical results between previously reported
data (Norén and Meironyte, 2000) and the results presented herein,
several samples were selected for reanalysis. The results from the twopg/g fat 2,3,7,8−TCDF
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Fig. 3. Temporal trends of 2,3,7,8-TCDF, 2,3,4,7,8-PCDF, 1,2,3,7,8-PCDF and 1,2,3,4,7,8-HCDF (p
based on log-linear regression analyses. The red non-linear lines (p b 0.05) are smoothers ﬁtteoccasions for analyses, 2000 and 2013, respectively, are visualized in
Fig. 5. The concentration differences are rather small, with the highest
discrepancy observed for the sample taken in 1972 (Fig. 5). Also, thepg/g fat 1,2,3,7,8−PCDF
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Fig. 4. Temporal trends of CB-118, CB-126 and CB-156 (pg/g fat) inmothers' milk from Stockholm, 1972–2011. The linear red lines (p b 0.05) are based on log-linear regression analyses.
The red non-linear lines (p b 0.05) are smoothers ﬁtted to the annual mean values. A red cross represents a suspected outlier.
230 J. Fång et al. / Environment International 60 (2013) 224–231relative proportions of∑PCDDs,∑PCDFs and∑DL-PCBs, are in rather
good agreement for all years. In some further detail, the previous anal-
ysis seems to have yielded a somewhat higher result on pg/g fat
∑TEQ1998 basis compared to the current study with the exception of
one of the samples, the one from 1980. Further, the mean and median
differences between the studies were 13 and 15%, respectively, on
∑TEQ1998 basis. The largest difference was found for∑PCDDs, mean
and median difference of 20% and 25% respectively. The differences for
∑DL-PCBs and ∑PCDFs were lower, approximately 10% mean and2000 2013 2000 2013 2000 2013 2000 2013 2000 2013 2000 2013 2000 2013 
1972 1976 1980 1990 1991 1992 1997
pg/g
Fig. 5. The concentrations of PCDD, PCDFs and DL-PCBs previously analyzed and reported
(Norén andMeironyte, 2000) compared to those presented in this study in the same sam-
ples, denoted 2000 and 2013 respectively. The TOTAL-TEQ-value (WHO1998) of each sam-
ple is divided in three segments:∑PCDDs,∑PCDFs and∑DL-PCBs.median difference for both groups of compounds. The result of this
part of the present study shows that direct comparison between histor-
ical data and new data is possible for monitoring of PCDDs, PCDFs and
DL-PBCs by applying the methodology described herein. Accordingly,
it is possible to elongate existing time trends with new samples.
Fig. 6 shows the quotas of the PCDDs, PCDFs and DL-PCBs of the
TOTAL-TEQ2005 for each sample of the time trend, 1972–2011, presented
herein. It can be generalized that half of the∑TEQ ismade up of DL-PCBs,
and the other half comprise of somewhat more PCDDs than PCDFs. Time
trend analyses of the three fractions show a relative annual decrease over
the 40 year period for the DL-PCBs, 0.44% per year (p b 0.49), but show
no statistical signiﬁcant trend for the last decade. The PCDDs and PCDFs
show no statistical signiﬁcant trend for either time period.
Comparability between studies from the literature, even when it
comes to the same matrix — mothers' milk, is strongly hampered by
several facts. First, the present lack of original congener speciﬁc data,
presented either on a weight basis or on a molar basis, that is necessary
to allow calculations of TEQs when new TEFs are applied, is not report-
ed. Further, congener speciﬁc data are the most reliable data as a base
for assessing temporal trends. Sum of analyte data may hide interesting
and relevant temporal trends, as discussed for the PCDFs above. Second,
the lack of uniﬁed sampling strategies inﬂuences the results. To pro-
mote the best possible sampling strategy it is relevant to apply the in-
structions from the WHO milk program (UNEP, 2012) or something as
close to this as possible. Third, the lack of long term temporal trend anal-
ysis strongly hampers spatial comparisons of such trends.
5. Conclusions
The rate of which∑PCDDs,∑PCDFs∑DL-PCBs and the∑TEQ are
decreasing (on pg/g fat WHO-TEQ2005) is steeper in the last decade com-
pared to the 40 year period, 1972–2011. The declines for PCDDs, PCDFs,
DL-PCBs and∑TEQs are 10%, 7.3%, 12% and 10% per year, last decade,
compared to 6.1%, 6.1%, 6.9%% and 6.5% per year, 1972–2011. The
Fig. 6. Composition of the time series from 1972 to 2011. The TOTAL-TEQ-value (WHO2005) of each sample is divided into three segments:∑PCDDs,∑PCDFs and∑DL-PCBs.
231J. Fång et al. / Environment International 60 (2013) 224–231difference in steepness, between the whole time period and the last ten
years, ismuch smaller for∑TEQ of PCDFs than for the other groups, likely
due to toomanyPCDF congeners belowLOQ, 2002–2011. The faster rate of
decline over this period of time is conﬁrmed by the temporal trends of the
individual “dioxins”, as determined on a weight basis. The faster drop in
“dioxin” concentrations inmothers' milk in Sweden is amirror of success-
fulmeasures for lowering dioxin exposures. The good agreement between
historical data and new data supports the elongation of existing monitor-
ing series or data points, within the monitoring program. In contrast, it is
still very difﬁcult to compare results between monitoring programs due
to differences in sampling strategies, reporting and lack of long term tem-
poral studies of dioxins in mothers' milk.
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